These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The clinical characteristics of retinal vasculitis in HLA-B27-positive patients. Braakenburg AM; Rothova A Ocul Immunol Inflamm; 2014 Jun; 22(3):197-202. PubMed ID: 24102118 [TBL] [Abstract][Full Text] [Related]
45. Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis. Karaca I; Uludag G; Matsumiya W; Regenold J; Or C; Mobasserian A; Halim MS; Zaidi M; Lajevardi S; Dongchau A; Ghoraba H; Nguyen QD Eye (Lond); 2023 Aug; 37(11):2197-2203. PubMed ID: 36443499 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH Poola N; Due B; Wright D; Brooks LR; Zaman F Clin Pharmacol Drug Dev; 2022 Apr; 11(4):502-515. PubMed ID: 34528408 [TBL] [Abstract][Full Text] [Related]
47. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304 [TBL] [Abstract][Full Text] [Related]
48. A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms. Duchowny MS; Chopra I; Niewoehner J; Wan GJ; Devine B J Health Econ Outcomes Res; 2021 Jan; 8(1):1-9. PubMed ID: 33521161 [No Abstract] [Full Text] [Related]
49. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis. Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV Front Immunol; 2020; 11():2071. PubMed ID: 33013877 [TBL] [Abstract][Full Text] [Related]
50. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089 [TBL] [Abstract][Full Text] [Related]
51. Single Dexamethasone Intravitreal Implant in the Treatment of Noninfectious Uveitis. Frère A; Caspers L; Makhoul D; Judice L; Postelmans L; Janssens X; Lefebvre P; Mélot C; Willermain F J Ocul Pharmacol Ther; 2017 May; 33(4):290-297. PubMed ID: 28448238 [TBL] [Abstract][Full Text] [Related]
54. Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis: Clinical Improvement with Infliximab. Samalia P; Sims J; Deva N Ocul Immunol Inflamm; 2023 Feb; 31(2):437-444. PubMed ID: 35081005 [TBL] [Abstract][Full Text] [Related]
55. Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography. Karampelas M; Sim DA; Chu C; Carreno E; Keane PA; Zarranz-Ventura J; Westcott M; Lee RW; Pavesio CE Am J Ophthalmol; 2015 Jun; 159(6):1161-1168.e1. PubMed ID: 25709064 [TBL] [Abstract][Full Text] [Related]
56. Clinical manifestations and treatment outcomes of syphilitic uveitis in HIV-negative patients in China: A retrospective case study. Zhu J; Jiang Y; Shi Y; Zheng B; Xu Z; Jia W Medicine (Baltimore); 2017 Oct; 96(43):e8376. PubMed ID: 29069031 [TBL] [Abstract][Full Text] [Related]
57. [Interferon and retinal vasculitis]. Fardeau C J Fr Ophtalmol; 2006 Apr; 29(4):392-7. PubMed ID: 16885805 [TBL] [Abstract][Full Text] [Related]
58. Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions. Agarwal A; Karkhur S; Aggarwal K; Invernizzi A; Singh R; Dogra MR; Gupta V; Gupta A; Do DV; Nguyen QD Clin Exp Ophthalmol; 2018 Jan; 46(1):62-74. PubMed ID: 28557287 [TBL] [Abstract][Full Text] [Related]
59. The course of retinal vasculitis. Ali A; Ku JH; Suhler EB; Choi D; Rosenbaum JT Br J Ophthalmol; 2014 Jun; 98(6):785-9. PubMed ID: 24511084 [TBL] [Abstract][Full Text] [Related]
60. Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion. Ryder SJ; Iannetta D; Bhaleeya SD; Kiss S Clin Ophthalmol; 2015; 9():1109-16. PubMed ID: 26150689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]